Phase II study of brigatinib in ROS1-positive non-small cell lung cancer patients previously treated with crizotinibYasushi Goto,Seiji Niho,Haruko Daga,Sakakibara-Konishi Sakakibara-Konishi,Hiroshi Tanaka,Kadoaki Ohashi,Ryo Toyozawa,Masahiro Kotani,Toshiaki Takahashi,Yoshihiro Hattori,Masahiro Morise,Takaya Ikeda,Shingo Matsumoto,Kiyotaka Yoh,Shogo Nomura,Koichi GotoANNALS OF ONCOLOGY(2022)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要